Recent data are not in conflict with homocysteine as a cardiovascular risk factor.
about
Molecular dissection of the S-adenosylmethionine-binding site of phosphatidylethanolamine N-methyltransferaseHepatic phosphatidylethanolamine N-methyltransferase, unexpected roles in animal biochemistry and physiologyPreventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.Therapeutic potential of total homocysteine-lowering drugs on cardiovascular disease.Hyperhomocysteinemia in chronic renal failure patients: relation to nutritional status and cardiovascular disease.Effect of Hyperhomocysteinemia on Redox Balance and Redox Defence Enzymes in Ischemia-Reperfusion Injury and/or After Ischemic Preconditioning in Rats.Polymorphism of MTHFR C677T, serum vitamin levels and cognition in subjects with hyperhomocysteinemia in China.Vitamin B-12 status is not associated with plasma homocysteine in parents and their preschool children: lacto-ovo, lacto, and ovo vegetarians and omnivores.Association of the C677T MTHFR polymorphism with homocysteine, ox-LDL levels, and thiolactonase activities in the severity of coronary syndrome.Maternal homozygosity for the common MTHFR mutation as a potential risk factor for offspring with limb defects.Total plasma homocysteine and related amino acids in end-stage renal disease (ESRD) patients measured by gas chromatography-mass spectrometry--comparison with the Abbott IMx homocysteine assay and the HPLC method.Homocysteine and coronary heart disease: the importance of a distinction between low and high risk subjects.Effect of vitamin B(6) vitamers on platelet aggregation.Higher plasma homocysteine is associated with increased risk of developing colorectal polyps.
P2860
Q28184815-A3394C4C-5810-4172-B62A-EDD49F5F7AF9Q28249732-046C5709-EEEF-47E3-BF85-A28257E757E7Q34038098-D93AA623-8298-4FAA-AF67-8C97090050FCQ34075182-09E9F92A-E3CC-41F3-BD2F-30B6B3EDEC45Q34395832-DB99D9BE-725E-46DC-B997-1B38E5B02EEFQ38756272-9AC26403-DF63-467F-9D33-28FB4C3646BDQ42952363-DCECB69E-EDA8-47F1-9CE9-775869886FC8Q42994200-A4D60963-69CD-4514-B343-44D7A092FB80Q43042066-E9298C68-C148-44C4-B7F5-C3B1BD4B3A12Q43598042-A626D8BB-46DC-4641-B0DC-AEA157BF23B6Q43760540-552F7916-ACAA-4867-8E54-6C609E78892DQ44286470-8009CA02-4445-4A75-B0E7-292D57DEED3AQ46113380-0C83C475-B993-4DC0-879F-6B78B38DF106Q51344139-907FB388-90B5-4470-8EC9-F97680066EAB
P2860
Recent data are not in conflict with homocysteine as a cardiovascular risk factor.
description
1998 nî lūn-bûn
@nan
1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Recent data are not in conflict with homocysteine as a cardiovascular risk factor.
@ast
Recent data are not in conflict with homocysteine as a cardiovascular risk factor.
@en
type
label
Recent data are not in conflict with homocysteine as a cardiovascular risk factor.
@ast
Recent data are not in conflict with homocysteine as a cardiovascular risk factor.
@en
prefLabel
Recent data are not in conflict with homocysteine as a cardiovascular risk factor.
@ast
Recent data are not in conflict with homocysteine as a cardiovascular risk factor.
@en
P1476
Recent data are not in conflict with homocysteine as a cardiovascular risk factor.
@en
P304
P356
10.1097/00041433-199812000-00004
P577
1998-12-01T00:00:00Z